US Stock MarketDetailed Quotes

NUVB Nuvation Bio

Watchlist
  • 2.800
  • +0.100+3.70%
Close Nov 22 16:00 ET
  • 2.730
  • -0.070-2.50%
Post 20:01 ET
942.39MMarket Cap-1284P/E (TTM)

About Nuvation Bio Company

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Company Profile

SymbolNUVB
Company NameNuvation Bio
Listing DateAug 26, 2020
Founded2018
CEODr. David T. Hung,M.D.
MarketNYSE
Employees51
Fiscal Year Ends12-31
Address1500 Broadway,Suite 1401
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-208-6102
Websitehttp://www.nuvationbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David T. Hung,M.D.
  • President, Chief Executive Officer and Director
  • 4.32M
  • Dr. Gary Hattersley, PhD
  • Chief Scientific Officer
  • 1.36M
  • Dr. David C. Hanley, PhD
  • Chief Technical Operations Officer
  • --
  • Philippe Sauvage
  • Chief Financial Officer
  • --
  • Dr. David Liu, M.D.,PhD
  • Chief Medical Officer
  • 1.34M
  • Colleen Sjogren
  • Chief Commercial Officer
  • --
  • Kerry Wentworth
  • Chief Regulatory Officer
  • --
  • Stacy Markel
  • Chief People Officer
  • --
  • Dr. Xiangmin Cui, PhD
  • Director
  • --
  • Dr. Junyuan Wang, PhD
  • Director
  • --
  • Robert B. Bazemore, Jr
  • Independent Director
  • 442.60K
  • Dr. Robert Mashal, M.D.
  • Independent Director
  • --
  • Kathryn E. Falberg
  • Independent Director
  • 447.77K
  • W. Anthony Vernon
  • Independent Director
  • 448.68K
  • Kim D. Blickenstaff
  • Independent Director
  • 440.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data